Old Web
English
Sign In
Acemap
>
authorDetail
>
Alessia Bottos
Alessia Bottos
Hoffmann-La Roche
Medicine
Diffuse large B-cell lymphoma
Cancer research
Nuclear medicine
fluorodeoxyglucose positron emission tomography
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Glofitamab (Glofit) in Combination with Polatuzumab Vedotin (Pola): Phase Ib/II Preliminary Data Support Manageable Safety and Encouraging Efficacy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
2021
Blood
Martin Hutchings
Anna Sureda
María José Terol
Francesc Bosch Albareda
Paolo Corradini
Thomas Stauffer Larsen
Antonio Rueda Dominguez
Anesh Panchal
Alessia Bottos
David Carlile
Yanjie Wang
Audrey Filézac de LÉtang
Maneesh Tandon
Gila Sellam
Giuseppe Gritti
Show All
Source
Cite
Save
Citations (0)
An EZH2 Gene Expression Signature Is Predictive of Differential Efficacy of Chemotherapy Irrespective of EZH2 Mutation Status in Patients with Follicular Lymphoma Treated within the Gallium Trial
2021
Blood
Verena Passerini
Vindi Jurinovic
Christopher R. Bolen
Andrea Knapp
Alessia Bottos
Julia Richter
Jude Fitzgibbon
Wolfram Klapper
Andrew Davies
Robert Marcus
Michael von Bergwelt
Tina Nielsen
Martin Dreyling
Wolfgang Hiddemann
Michael Unterhalt
Eva Hoster
Oliver Weigert
Show All
Source
Cite
Save
Citations (0)
Automated Baseline Fluorodeoxyglucose-Positron Emission Tomography Imaging and High BCL2 Expression Provide Orthogonal Prognostic Value in Predicting High-Risk De Novo Diffuse Large B-Cell Lymphoma Patients
2020
Blood
Skander Jemaa
Samuel Tracy
Alessia Bottos
Alex de Crespigny
Thomas Bengtsson
Tina Nielsen
Joseph N. Paulson
Show All
Source
Cite
Save
Citations (0)
1